Back to Journals » OncoTargets and Therapy » Volume 12

Original Research

Apatinib Plus Temozolomide for Recurrent Glioblastoma: An Uncontrolled, Open-Label Study

       
Total article views   HTML views PDF downloads Totals
7,367 Dovepress* 6,704+ 665 7,369
PubMed Central* 663 249 912
Totals 7,367 914 8,281
*Since 3 December 2019

View citations on PubMed Central and Google Scholar